My Member
Message Center
trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
-
Single-shot CanSino vaccine also stands out for being easier to store
The COVID-19 vaccine candidate manufactured by Chinese firm CanSino Biologics has an overall efficacy rate of 65.7 percent at preventing symptomatic cases and is 90.98 percent effective in preventing severe disease with a single injection.
2021-02-23 -
Countries lining up to obtain Sinovac COVID-19 vaccines
Countries, including Indonesia, the Philippines, Thailand and Nigeria, are cooperating with China in procuring or rolling out COVID-19 vaccines produced by the Chinese pharmaceutical company Sinovac, according to the South China Morning Post.
2021-01-19 -
Turkey approves China's Sinovac jab
ANKARA - Turkey on Wednesday approved the emergency use of a coronavirus jab developed by China's Sinovac, paving the way for a national vaccination drive that will start with healthcare workers.
2021-01-14 -
Internet hospital helps cure Tumxuk patients
People in Tumxuk, Xinjiang Uygur autonomous region, are enjoying more convenient medical treatment and a wider range of cultural choices thanks to ongoing support from Dongguan, Guangdong province.
2021-01-13 -
Inactivated vaccines can't end outbreak, but suitable to protect general public: experts
Experts explained although the approved inactivated vaccines cannot cure the infected, they are suitable for China to protect the general public.
2021-01-07 -
Biotech firm makes test kit for new virus variant
BGI Genomics, a Shenzhen-based biotech company, on Tuesday announced the successful development of a rapid detection kit for the new strain of the novel coronavirus, known as SARS-CoV-2 B.1.1.7, which was originally discovered in the UK.
2021-01-06 -
Sinopharm's vaccine shows protection rate of over 79%
Sinopharm's COVID-19 vaccine can induce neutralizing antibody in 99.52 percent of recipients, and has a 79.34 percent efficacy rate, according to midterm clinical results released on Wednesday.
2020-12-30 -
Drug offers new way to limit spread of HIV
The market launch of a drug that prevents HIV infection, the first of its kind in China, will contribute to the fight against the AIDS disease the virus can cause, leading medical experts said.
2020-12-28 -
China's self-developed lung cancer drug available nationwide
HANGZHOU - Ensartinib hydrochloride, a targeted drug for lung cancer developed by a Chinese firm, has been available in hospitals and pharmacies nationwide since Wednesday, according to its developer Beta Pharma.
2020-12-22 -
Official affirms safety of Chinese vaccines
Experimental COVID-19 vaccines developed by Chinese researchers are safe, and ongoing efforts to push for their market approval will strictly follow the rules of science, a health official said on Monday.
2020-12-22